Search
for
Sort by
Research 181–210 of 746
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
- In vitro 5α-reductase inhibition by selected Ayurvedic herbs for androgenic disorders
- Protective role of hesperidin in finasteride-induced testicular toxicity in adult male Wistar rats: Insights into oxidative stress, apoptosis, and ultrastructure of seminiferous tubules
- Disorders in Male Sexual Differentiation Due to 5α-Reductase-2 Deficiency
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Differential expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation in the mouse
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera.
- Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation
- Finasteride and sexual side effects
- Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)
- Finasteride-its impact on sexual function and prostate cancer
- Risks and side effects in the medical management of benign prostatic hyperplasia
- 13C-NMR study of 4-azasteroids in solution and solid state
- Testosterone-stimulated weanlings as an alternative to castrated male rats in the Hershberger anti-androgen assay
- Clinical review of ejaculatory dysfunction
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants
- Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants
- The prevention of benign prostatic hyperplasia (bph)
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.